U.S stock market after four days consecutive gain, ended lower on Friday. For every three stocks mounting, nearly four cut down on the New York Stock Exchange, where 785 million shares traded. Composite volume cleared 3.6 billion.
Crude outlooks for March delivery vacillated between gains and losses before concluding at $45.59 a barrel, off 72 cents, or 1.6 percent, on the New York Mercantile Exchange.
The February gold contract dropped $8.10, or 0.6 percent, to $1,292.60.
Including the euro, the U.S. dollar strengthened against other global currencies, with fear that an anti-austerity party would claim victory in Greece elections on Sunday escalating the currency’s drop after the European Central Bank expanded incentive.
Here are listed few well-known stocks from different sectors, along with their very latest TRENDS and NEWS.
In technology sector, Finisar Corp. (NASDAQ:FNSR), inclined 2.07% to settle at $19.75, during its last trading session. The company has market capitalization of $2.04B. Its traded in a range of $19.44 - $19.95.
Finisar Corp. (NASDAQ:FNSR), provides optical subsystems and components for data communication and telecommunication applications in the United States, Malaysia, China, and internationally.
From financial sector, NorthStar Realty Finance Corp. (NYSE:NRF), surged 0.74% to settle at $19.09, during its last trading session.
The firm formerly declared that it has reached a definitive contract to attain a €1.1 billion European office portfolio in cooperation with Cale Street Partners. The Portfolio is comprised of 11 Class A office properties positioned across gateway cities in seven of Europe’s top markets: London, UK; Paris, France; Hamburg, Germany; Milan, Italy; Brussels, Belgium; Amsterdam and Rotterdam, Netherlands; and Gothenburg, Sweden. The Portfolio comprises of 186,299 square meters (2 million square feet) with a well-diversified mix of market leading tenants.
NorthStar Realty Finance Corp. (NYSE:NRF), is a diversified commercial real estate company that is organized as a REIT. NorthStar Realty is managed by an affiliate of NorthStar Asset Management Group Inc. (NSAM), a global asset management firm. For more information about NorthStar Realty Finance Corp., please visit www.nrfc.com.
Among energy shares, Valero Energy Corporation (NYSE:VLO), went up 4.50% to settle at $50.16, as the Board of Directors of the company has approved an increase in the company’s regular quarterly cash dividend on ordinary stock from $0.275 per share to $0.40 per share, effective with the quarterly dividend the Board has affirmed to be payable on March 3, 2015 to holders of record at the close of business on February 11, 2015. The boost in the dividend raises the annualized cash dividend rate on Valero’s ordinary stock to $1.60 per share.
Valero Energy Corporation (NYSE:VLO), through its subsidiaries, is an international manufacturer and marketer of transportation fuels, other petrochemical products and power.
Alcoa Inc. (NYSE:AA), belongs to basic material sector and during its last trading session, the company declined 1.75% to close at $15.76, following the news that the firm declared that its Board of Directors has elected L. Rafael Reif a director of the Company effective March 2, 2015. Dr. Reif, 63, is president of the Massachusetts Institute of Technology (MIT), the world renowned educational institution of science and technology. He has been a faculty member of MIT for more than 30 years.
A global leader in lightweight metals technology, engineering and manufacturing, Alcoa Inc. (NYSE:AA), multi-material solutions that advance our world.
From Biotech sector, Rockwell Medical, Inc. (NASDAQ:RMTI), augmented 3.44% to settle at $10.81, as a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, declared that two individual abstracts for Triferic have been chosen by the Annual Dialysis Conference for presentation at their Annual Meeting, January 31 — February 3, 2015 in New Orleans, Louisiana. Triferic is the Company’s late-stage investigational iron-replacement drug for the treatment of iron deficiency in chronic kidney disease patients receiving hemodialysis.
